Four in Custody, 50 crore worth psychotropic drugs seized from 2 firms

  • News
  • September 1, 2016

Mumbai – The Narcotic Control Bureau (NCB) raided two pharma companies, in Vadodara and MIDC Andheri in Mumbai, and seized antidepressant tablets, that falls under the Narcotic Drugs and Psychotropic Substances Act, worth Rs 50 crore in western markets. The NCB have also arrested four persons, including two directors of the companies. “The accused were likely to misdeclare the medicines and export them to the US and the UK,” said Hari Gandhi, director of NCB’s Ahmedabad zone.

On August 10, the NCB’s Ahmedabad unit conducted a raid on Dolphin Pharma in Vadodara and seized around nine lakh tablets of Zolpidem, Alprazolam and Oxycodone – antidepressant tablets that cannot be sold without prescription. The company’s director Anil Lohar and manager Zahid Shaikh were arrested under the NDPS Act. There is lot to uncover in controlled drug substances in India. Any illegal activity has lot of scope in india, because laws can be flaunted easily. During their interrogation, they revealed that these drugs were supplied by Mumbai-based KC Pharma.

Subsequently, NCB’s Mumbai unit on Monday raided KC Pharma at MIDC Andheri and seized very large quantities of Diazepam, Zolpidem, Lorazepam and Clonazepam. The company’s director, Krishnan Choudhary, along with its manager, S Murugan, was arrested. Officials said they have recovered documents and emails to show the cover up. “We are trying to figure out whether if these firms have already exported any medicines,” an official said.

Related Posts

Centre Pushes Haryana to Fast-Track AIIMS Rewari

New Delhi | August 18, 2025 — The Union government has urged Haryana to speed up work on AIIMS Rewari (Majra) and resolve on-ground hurdles so the institute can open…

Rajasthan Drops 1,114 Hospitals From RGHS in Fraud Drive

Jaipur, August 18, 2025 — Rajasthan has removed 1,114 private hospitals from the Rajasthan Government Health Scheme (RGHS) after a statewide fraud sweep. The Health Department also suspended 1,901 healthcare…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

Obesity drug market to gain as Indians pop the pill and Chinese bring more

Obesity drug market to gain as Indians pop the pill and Chinese bring more

Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

Boehringer Ingelheim launches AI centre for pharma research in London

Boehringer Ingelheim launches AI centre for pharma research in London

Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March

Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March